Provided by Tiger Trade Technology Pte. Ltd.

MSA Safety

178.70
-1.1200-0.62%
Post-market: 178.700.00000.00%19:30 EDT
Volume:233.01K
Turnover:41.79M
Market Cap:6.89B
PE:22.22
High:181.76
Open:181.76
Low:178.10
Close:179.82
52wk High:208.92
52wk Low:151.11
Shares:38.58M
Float Shares:36.18M
Volume Ratio:1.21
T/O Rate:0.64%
Dividend:2.13
Dividend Rate:1.19%
EPS(TTM):8.04
EPS(LYR):7.09
ROE:23.66%
ROA:11.07%
PB:4.93
PE(LYR):25.20

Loading ...

MSA Safety Inc : B. Riley Cuts to Neutral from Buy; Cuts Target Price to $195 from $210

THOMSON REUTERS
·
Aug 03

B. Riley Downgrades MSA Safety to Neutral From Buy, Adjusts Price Target to $195 From $210

MT Newswires Live
·
Aug 03

MSA Safety is Maintained at Neutral by Baird

Dow Jones
·
Aug 03

OwlTing Group (NASDAQ: OWLS) Reports OwlPay Harbor July Payment Volume Increased 107.6% Month Over Month

GlobeNewswire
·
Aug 03

MSA Safety price target raised to $215 from $197 at Baird

TIPRANKS
·
Aug 03

MSA Safety up over 11%, on Pace for Largest Percent Increase Since October 2022

Dow Jones
·
Aug 01

Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab

GlobeNewswire
·
Jul 31

Perimeter Solutions Q2 Sales Rise on Specialty Products Growth

Reuters
·
Jul 31

MSA Safety Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

MSA Safety Buys Autronica Fire and Security for About $555 Million

Reuters
·
Jul 31

MSA Safety Q2 FY26 GAAP Diluted EPS Rises 40% to $2.23; Net Sales Increase 6% to $503 Million

Reuters
·
Jul 31

MSA Safety Q2 Adjusted Earnings, Revenue Rise

MT Newswires Live
·
Jul 31

MSA Safety reports Q2 adjusted EPS $2.40, consensus $2.14

TIPRANKS
·
Jul 31

MSA Safety Q2 Adj. EPS $2.40 Beats $2.13 Estimate, Sales $503.327M Beat $496.318M Estimate

Benzinga Earnings
·
Jul 31

MSA Safety Q2 Adjusted EPS USD 2.4 Vs. IBES Estimate USD 2.14

Reuters
·
Jul 31

MSA Safety Q2 EPS USD 2.23

THOMSON REUTERS
·
Jul 31

Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update

GlobeNewswire
·
Jul 30

ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease

GlobeNewswire
·
Jul 28

Is MSA Safety (MSA) A Bargain After Its New Board Appointment?

Simply Wall St.
·
Jul 27

MSA Safety Director Octavio Marquez Files Initial Beneficial Ownership Statement

Reuters
·
Jul 23